Thomas Vasicek, PHD

Dr. Vasicek is an experienced biotech industry executive with extensive startup experience, including Millennium, LabSeek, Lynx, HTG and PanGenX.  He has established new ventures within Corning, Medtronic and Roche.  Dr. Vasicek’s first scientific investigations in endocrinology began in the 1980s.  In the 1990s he began working with obesity genes at Millennium.  At Medtronic he led development of gut hormone therapies for obesity and clinical trials of pump-delivered interferon alpha for hepatitis-C.  He has been successful at raising financing, launching products, and buying and selling companies. Dr. Vasicek holds a BS in Chemistry from MIT and a PhD in Genetics from Harvard, and has authored 26 publications, three issued patents and seven patent applications.